NEWS

GA_P advises Atrys Health on its entry into the Continuous Market

icon 4 of February, 2022
GA_P advises Atrys Health on its entry into the Continuous Market

Gómez-Acebo & Pombo has advised Atrys Health on its entry into the Continuous Market and its shares will start trading on the Madrid, Barcelona, Bilbao and Valencia Stock Exchanges next Monday, February 7. Atrys makes the leap to the Continuous Market with the aim of incorporating international equity funds as shareholders.

Atrys is currently listed on the BME Growth with a market capitalization of 600 million euros. Atrys is a global company that provides diagnostic services and precision medical treatment, pioneer in telemedicine and state-of-the-art radiotherapy. In terms of revenue, its turnover has grown from €4.5 million in 2016 to a proforma turnover of over €85 million in the first half of 2021 alone. And in that same period of just 6 years, it has grown from a team of 44 professionals to more than 2,000 today.

The GA_P team has been led by Guillermo Guerra, Corporate partner, and integrated by Jacobo Palanca and Irene Carreño Uría, Corporate associates, and Irene Medina, Banking associate.

Autor/s

Guillermo Guerra – Partner

Jacobo Palanca – Senior Associate

Tipology

Deal

Areas and sectors

Corporate Governance

Press contact

Sandra Cuesta
Sandra Cuesta
Director of Business Development, Marketing and Communications
Sandra Cuesta
Sandra Cuesta
Director of Business Development, Marketing and Communications
icon
icon

More information about
Gómez-Acebo & Pombo

icon
icon
icon
icon